Revvity (RVTY) Cash from Investing Activities (2009 - 2026)
Revvity (RVTY) posted Cash from Investing Activities of -$78.3 million for Q2 2026, down 318.65% quarter-over-quarter from $35.8 million in Q4 2025, and down 396.87% year-on-year from $26.4 million in Q2 2025.
Revvity (RVTY) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Revvity (RVTY) has reported Cash from Investing Activities for 18 consecutive years, with -$78.3 million the latest figure, recorded in Q2 2026.
- Cash from Investing Activities for Q2 2026 came in at -$78.3 million, down 396.87% year-over-year; the trailing twelve-month figure through Apr 2026 was -$79.9 million (down 112.85% YoY), and the FY2025 annual result was -$17.4 million, down 102.8% from the prior year.
- Cash from Investing Activities was -$78.3 million for Q2 2026 at Revvity, down from $35.8 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $3.9 billion in Q1 2023 and troughed at -$556.7 million in Q3 2023.
- Average Cash from Investing Activities over 5 years is $380.0 million, with a median of -$18.5 million recorded in 2025.
- Year-over-year, Cash from Investing Activities surged 120.55% in 2025 and tumbled 396.87% in 2026.
- Over 5 years, Cash from Investing Activities stood at -$48.6 million in 2022, then surged by 3515.56% to $1.7 billion in 2023, then slumped by 110.5% to -$174.2 million in 2024, then jumped by 120.55% to $35.8 million in 2025, then slumped by 318.65% to -$78.3 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$78.3 million in Q2 2026, $35.8 million in Q4 2025, and -$18.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -32.14 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -77.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -196.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Revvity | 12.62 Bn | 11.76 Bn | 387.66 Mn | -78.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -78.27 Mn |
| Apr 5, 2026 | -78.27 Mn |
| Dec 28, 2025 | 35.80 Mn |
| Dec 28, 2025 | 35.80 Mn |
| Sep 28, 2025 | -18.53 Mn |
| Sep 28, 2025 | -18.53 Mn |
| Jun 29, 2025 | -18.87 Mn |
| Jun 29, 2025 | -18.87 Mn |
| Mar 30, 2025 | -15.75 Mn |
| Mar 30, 2025 | -15.75 Mn |
| Dec 29, 2024 | -174.23 Mn |
| Dec 29, 2024 | -174.23 Mn |
| Sep 29, 2024 | 837.70 Mn |
| Sep 29, 2024 | 837.70 Mn |
| Jun 30, 2024 | -26.03 Mn |
| Jun 30, 2024 | -26.03 Mn |
| Mar 31, 2024 | -18.18 Mn |
| Mar 31, 2024 | -18.18 Mn |
| Dec 31, 2023 | 1.66 Bn |
| Dec 31, 2023 | 1.66 Bn |